IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy

AIMS: Basal–bolus therapy is associated with greater treatment burden and lower adherence compared with more simplified regimens. This post hoc analysis studied the difference between insulin degludec/liraglutide (IDegLira) and basal–bolus therapy on number of injections, dose adjustments and patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Eden, Doshi, Ankur, Grøn, Randi, Jódar, Esteban, Őrsy, Petra, Ranthe, Mattis F., Sugimoto, Danny, Tentolouris, Nikolaos, Viljoen, Adie, Billings, Liana K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899651/
https://www.ncbi.nlm.nih.gov/pubmed/31385425
http://dx.doi.org/10.1111/dom.13851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899651/
https://www.ncbi.nlm.nih.gov/pubmed/31385425
http://dx.doi.org/10.1111/dom.13851

Ejemplares similares